Department of Cardiothoracic Radiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK Correspondence to Dr Stephen P Harden, Department of Cardiothoracic Radiology, University ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...

Rationale The accumulated prevalence of obesity, diabetes, and metabolic syndrome is more than 25% of the world’s population. These are all conditions that have been repeatedly related to a higher ...

Cardiovascular diseases i are the most common cause of loss of flying licence globally, and cardiac arrhythmia is the main disqualifier in a substantial proportion of aircrew. Aircrew ii often operate ...

Established in 2018, the Global Cardiovascular Research Funders Forum (GCRFF) unites 12 leading charitable and public ...

Correspondence to Dr Russell James Everett, BHF/Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4SB, UK; russell.everett{at}ed.ac.uk To review the pathophysiology of ...

Cardiac Unit, Institute of Child Health, University College London, UK Professor Robert Anderson, Cardiac Unit, Institute of Child Health, University College London ...

Background: Cardiac resynchronisation therapy (CRT) improves symptoms and prognosis in patients with heart failure and cardiac dyssynchrony. Guidelines from the National Institute of Health and ...

a Department of Cardiology, University Hospital, Rennes, France, b Department of Infectious Diseases and Medical Intensive Care Unit, University Hospital Dr Claude Daubert, Centre Hospitalier ...

2 School of Medicine, The University of Queensland, Brisbane, Australia 3 Department of Epidemiology and Biostatistics, School of Population Health, The University of Queensland, Brisbane, Australia 4 ...

Background Vasoreactivity testing is recommended in the management of pulmonary arterial hypertension (PAH), but its clinical relevance in congenital heart disease (CHD)-associated PAH has not been ...

Background: Angiotensin 1 converting enzyme (ACE) inhibitors reduce morbidity and mortality after coronary artery bypass graft surgery (CABG). This benefit may result from an anti-inflammatory action.